Britain’s AstraZeneca has secured a new European approval for heart med Forxiga (dapagliflozin), an innovative medicine known in the USA as Farxiga. 8 February 2023
The European Medicines Agency (EMA) has issued an update on ongoing shortages of antibiotic medicines containing amoxicillin—alone and in combination with clavu 27 January 2023
Already expected to reach blockbuster status with its 2022 sales, AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has won another approval in 26 January 2023
The European Medicines Agency is to review a regulatory submission from Swiss gene-editing specialist CRISPR Therapeutics and partner Vertex Pharmaceutical. 25 January 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.